Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern]

Huang L, Li G, Zhu J, Li Z, Li T, Leng X. Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study. Onco Targets Ther. 2012;5:457–462. The Editor-in-Chief and Publisher of OncoT...

Full description

Bibliographic Details
Main Authors: Huang L, Li G, Zhu J, Li Z, Li T, Leng X
Format: Article
Language:English
Published: Dove Medical Press 2020-04-01
Series:OncoTargets and Therapy
Online Access:https://www.dovepress.com/eoc-efficacy-of-sorafenib-after-liver-transplantation-in-patients-with-peer-reviewed-article-OTT
id doaj-9e30e0a813be4162a5dd230b0a3643a6
record_format Article
spelling doaj-9e30e0a813be4162a5dd230b0a3643a62020-11-25T03:10:14ZengDove Medical PressOncoTargets and Therapy1178-69302020-04-01Volume 133289329053158Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern]Huang LLi GZhu JLi ZLi TLeng XHuang L, Li G, Zhu J, Li Z, Li T, Leng X. Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study. Onco Targets Ther. 2012;5:457–462. The Editor-in-Chief and Publisher of OncoTargets and Therapy wish to issue an Expression of Concern for the published article. Concerns have been raised that the study described in the article did not adhere to ethical guidelines as outlined in the Declaration of Helsinki and the Declaration of Istanbul and guidance from the World Health Organization and the World Medical Association regarding the source of transplanted human organs. Specifically, the British Medical Journal Open (BMJ Open) published an article highlighting many papers in which there is concern that transplanted organs were harvested from executed prisoners in China. In response to these concerns we contacted the authors to clarify the source of the transplanted organs received by the patients described in their study. However, despite multiple attempts to contact the authors and their institutions, no response was received. The Editors of OncoTargets and Therapy would like to alert readers of this. We will provide an update if we receive any further information. OncoTargets and Therapy publishes research adhering to internationally accepted ethical standards and is committed to upholding the Declaration of Helsinki and Declaration of Istanbul. Dove Medical Press endorses the ethics guidelines described by the World Health Organization (WHO) and the World Medical Association (WMA). Read the original article  https://www.dovepress.com/eoc-efficacy-of-sorafenib-after-liver-transplantation-in-patients-with-peer-reviewed-article-OTT
collection DOAJ
language English
format Article
sources DOAJ
author Huang L
Li G
Zhu J
Li Z
Li T
Leng X
spellingShingle Huang L
Li G
Zhu J
Li Z
Li T
Leng X
Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern]
OncoTargets and Therapy
author_facet Huang L
Li G
Zhu J
Li Z
Li T
Leng X
author_sort Huang L
title Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern]
title_short Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern]
title_full Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern]
title_fullStr Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern]
title_full_unstemmed Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Expression of concern]
title_sort efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the milan criteria: a preliminary study [expression of concern]
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2020-04-01
description Huang L, Li G, Zhu J, Li Z, Li T, Leng X. Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study. Onco Targets Ther. 2012;5:457–462. The Editor-in-Chief and Publisher of OncoTargets and Therapy wish to issue an Expression of Concern for the published article. Concerns have been raised that the study described in the article did not adhere to ethical guidelines as outlined in the Declaration of Helsinki and the Declaration of Istanbul and guidance from the World Health Organization and the World Medical Association regarding the source of transplanted human organs. Specifically, the British Medical Journal Open (BMJ Open) published an article highlighting many papers in which there is concern that transplanted organs were harvested from executed prisoners in China. In response to these concerns we contacted the authors to clarify the source of the transplanted organs received by the patients described in their study. However, despite multiple attempts to contact the authors and their institutions, no response was received. The Editors of OncoTargets and Therapy would like to alert readers of this. We will provide an update if we receive any further information. OncoTargets and Therapy publishes research adhering to internationally accepted ethical standards and is committed to upholding the Declaration of Helsinki and Declaration of Istanbul. Dove Medical Press endorses the ethics guidelines described by the World Health Organization (WHO) and the World Medical Association (WMA). Read the original article  
url https://www.dovepress.com/eoc-efficacy-of-sorafenib-after-liver-transplantation-in-patients-with-peer-reviewed-article-OTT
work_keys_str_mv AT huangl efficacyofsorafenibafterlivertransplantationinpatientswithprimaryhepaticcarcinomaexceedingthemilancriteriaanbsppreliminarystudyexpressionofconcern
AT lig efficacyofsorafenibafterlivertransplantationinpatientswithprimaryhepaticcarcinomaexceedingthemilancriteriaanbsppreliminarystudyexpressionofconcern
AT zhuj efficacyofsorafenibafterlivertransplantationinpatientswithprimaryhepaticcarcinomaexceedingthemilancriteriaanbsppreliminarystudyexpressionofconcern
AT liz efficacyofsorafenibafterlivertransplantationinpatientswithprimaryhepaticcarcinomaexceedingthemilancriteriaanbsppreliminarystudyexpressionofconcern
AT lit efficacyofsorafenibafterlivertransplantationinpatientswithprimaryhepaticcarcinomaexceedingthemilancriteriaanbsppreliminarystudyexpressionofconcern
AT lengx efficacyofsorafenibafterlivertransplantationinpatientswithprimaryhepaticcarcinomaexceedingthemilancriteriaanbsppreliminarystudyexpressionofconcern
_version_ 1724659778778562560